T1	intervention 650 709	cognitive-behavioral side-effect prevention training (SEPT)
T2	No-of-participants 844 847	184
T3	control 915 936	standard medical care
T4	control 942 971	manualized supportive therapy
T5	outcome-Measure 1314 1376	Side effects three months after the start of endocrine therapy
T6	outcome-Measure 1431 1446	quality of life
T7	outcome-Measure 1448 1462	coping ability
T8	outcome-Measure 1467 1497	patients' medication adherence
T9	outcome-Measure 1499 1521	Patients' expectations
